Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3703-0.0046 (-1.23%)
At close: 04:00PM EDT
0.3709 +0.00 (+0.16%)
After hours: 07:34PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • L
    Lambrusco
    The real challenge this company has is NOT compliance, it is funding--they are almost out of cash...Again. Compliance keeps them on the Nasdaq, but it doesnt get them cash. And they are also running out of authorized shares to dilute from. The R/S allows them to dilute using less shares vis-a-vis the higher shareproce. Now they CAN increase the authorized share count with a vote, but they prefer the easier/artificial mode via the r/s.
    My PERSONAL concern is the lack of PR on Zimhi sales which would suggest (to me) thise sales aren't impressive enough for a Press Release nor enough to boost the shareprice.
    Moving to OTC wouldn't help things but it also forces the company to PERFORM. Sadly, I think they are toast---which includes my shares I've been holding for years.
    For the record I voted NO on R/S, even though I believe that will only hasten company demise.
    Oh, and Tempol sales are at least 2 years away; do the math. And if you don't agree with my timeline, show me your timeline.
  • P
    Peloton
    If tempol data in September is strong we will not need a reverse split to regain compliance
  • s
    stemcell_is_future
    If you can't run the company than you should sell it and give the money back to investors.
    Respect peoples hard earned money 🙏 Amen
  • J
    John
    Wish that this company will go to he’ll!
  • s
    stemcell_is_future
    When is the trial 2/3 tempol supposed to end? They should know the date. Let us know what you think?
  • s
    stemcell_is_future
    I voted against 99% of proposal🙏They have to try harder. Must communicate better than this. Must have chemistry with customers and partners and donors... They have to learn how to do business. I worked for more than 30 companies in my life so I know what to say 🙏Amen Amen Hallelujah
  • p
    polarboy45
    Who is this E. Kevin guy who believes it’s the shareholders fault for the stock price being where it has been? Does any employee at Adamis know what accountability is ? My goodness
  • E
    E. Kevin
    I was a purchaser today and looking forward to earnings call and keeping my fingers crossed that we can gain NASDAQ compliance once again concerning same. Still consider reverse split should be made available to management rather than diluting our holdings with the issuance of any more shares under one dollar.
    Bullish
  • J
    Joe
    FYI ADMP was granted the 6 month extension for price compliance on June 30th, it's outlined at the end of page 14 of the14A filed on July 7th.
  • C
    Clancy
    Let them make their money the old fashion way EARN IT.
    Not begging for it.
  • P
    Patrick Kiernan
    Board looking to reverse split….VOTE NO NO NO
  • J
    Joe
    I'm a bit surprised by the amount of selling if the letter is the main reason, what else was expected from a letter to shareholders outlining why they want you to vote in line with the board. There view was outlined weeks ago.
  • J
    John
    R/S 2009
    R/S 2013
    R/S 2022
    Stop and vote “NO” TO ALL
    Bearish
  • L
    Lambrusco
    I don't know about you, but the Letter to Shareholders did nothing to persuade me to vote Yes. Expand the pipeline??? They have yet to prove they can efficiently execute (trials, approve and commercialize) the current pipeline! And they are asking for more outstanding shares to dilute further? Sounds like more "good money after bad" to me. I don't want delisting, but they have 6 months to prove Zimhi and Symjepi sales can move the shareprice over $1 else it WILL be the pink sheets for this stock.
  • P
    Peloton
    Give the new guy a chance.
  • T
    Terry
    Could we possibly get some good news that Zimhi is selling and the problem with Symjepi has been corrected? The company has no news since June 1st and hopefully they are waiting until the next earnings report to give us stockholders news. I’m not holding my breath but I’m sure they don’t want to see the stock go to the pink pages ( which could happen in the near future)!
    Bearish
  • m
    marc
    This letter sounds like a kid begging his parent for some candy at the checkout counter. Hilarious
  • C
    Clancy
    Market don't like REVERSE SPLIT follows by DILUTION to finance the management high pay.
    They have to learn to sell products and generate income to get paid.
    Down she goes, next stop 20 cents.
  • Z
    Zhe
    The pick that was just sent out by (http://traderspot.club) is already up yuge! Check it out!
  • s
    stemcell_is_future
    If Bill Gates will give all of his money away why can't he supports Tempol? 👇
    In a Twitter thread, Mr Gates said the foundation would boost its spending from $6bn a year to $9bn by 2026 due to recent "global setbacks" including the pandemic, Ukraine and the climate crisis.
    "As I look to the future, I plan to give virtually all of my wealth to the foundation," he said. "I will move down and eventually off of the list of the world's richest people.
    "I have an obligation to return my resources to society in ways that have the greatest impact for reducing suffering and improving lives. And I hope others in positions of great wealth and privilege will step up in this moment too."
Advertisement
Advertisement